CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionJump Financial, LLC
Latest Disclosed Ownership160,138 shares
Latest Disclosed Value $ 47,296,758
Jump Financial, LLC reports 53.59% increase in ownership of MX4A / CME Group Inc.

On May 14, 2026 - Jump Financial, LLC filed a 13F-HR form disclosing ownership of 160,138 shares of CME Group Inc. (DE:MX4A) valued at $40,907,252 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 104,266 shares of CME Group Inc.. This represents a change in shares of 53.59% during the quarter. The current value of the position is $34,878,056 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CME Group Common Stock 12572Q105 160,138 55,872 53.59 47,297 66.11 0.5630
2026-02-17 2025-12-31 13F CME Group Common Stock 12572Q105 104,266 -53,730 -34.01 28,473 -33.30 0.3498
2025-11-13 2025-09-30 13F CME Group Common Stock 12572Q105 157,996 49,841 46.08 42,689 43.21 0.5108
2025-08-13 2025-06-30 13F CME Group Common Stock 12572Q105 108,155 -19,472 -15.26 29,810 -11.96 0.3283
2025-05-14 2025-03-31 13F CME Group Common Stock 12572Q105 127,627 23,168 22.18 33,858 39.57 0.4654
2025-02-13 2024-12-31 13F CME Group Common Stock 12572Q105 104,459 -108,542 -50.96 24,259 -48.39 0.5065
2024-11-14 2024-09-30 13F CME Group Common Stock 12572Q105 213,001 67,743 46.64 46,999 64.58 0.9582
2024-11-14 2024-06-30 13F/A-1 CME Group Common Stock 12572Q105 145,258 26,898 22.73 28,558 12.07 0.5706
2024-08-14 2024-06-30 13F CME GROUP Common Stock 12572Q105 145,258 26,898 28,558 0.5706
2024-05-13 2024-03-31 13F CME GROUP Common Stock 12572Q105 118,360 47,981 68.18 25,482 71.92 0.6976
2024-10-21 2023-12-31 13F/A-2 CME GROUP COM 12572Q105 70,379 -66,469 -48.57 14,822 -45.91 14.7984
2024-10-21 2023-12-31 13F/A-1 CME Group Common Stock 12572Q105 34,010 -102,838 7,163 0.1562
2024-02-07 2023-12-31 13F CME GROUP Common Stock 12572Q105 34,389 -102,459 7,242 0.2394
2024-10-21 2023-09-30 13F/A-1 CME Group Common Stock 12572Q105 136,848 66,848 95.50 27,400 118.98 1.0348
2023-11-07 2023-09-30 13F CME GROUP Common Stock 12572Q105 66,848 -3,152 13,384 0.5119
2024-10-21 2023-06-30 13F/A-2 CME GROUP COM 12572Q105 70,000 0 0.00 12,512 -3.57 24.5900
2024-10-21 2023-06-30 13F/A-1 CME GROUP Common Stock 12572Q105 58,979 -11,021 10,928 0.2378
2023-08-07 2023-06-30 13F CME GROUP Common Stock 12572Q105 58,979 -11,021 10,928 0.4116
2024-10-21 2023-03-31 13F/A-2 CME GROUP COM 12572Q105 70,000 0 0.00 12,975 10.23 24.6392
2024-10-21 2023-03-31 13F/A-1 CME Group Common Stock 12572Q105 34,644 -35,356 6,635 0.1769
2023-05-03 2023-03-31 13F CME GROUP Common Stock 12572Q105 34,644 -35,356 6,635 0.2760
2024-09-06 2022-12-31 13F/A-1 CME GROUP COM 12572Q105 70,000 0 0.00 11,771 -5.06 79.7137
2023-02-14 2022-12-31 13F CME GROUP Common Stock 12572Q105 76,121 38,900 12,801 0.6784
2024-09-06 2022-09-30 13F/A-1 CME GROUP COM 12572Q105 70,000 0 0.00 12,399 -13.47 74.9847
2022-11-07 2022-09-30 13F CME GROUP Common Stock 12572Q105 37,221 1,598 6,593 0.2581
2024-09-06 2022-06-30 13F/A-1 CME GROUP COM 12572Q105 70,000 0 0.00 14,329 -13.94 77.7936
2022-08-09 2022-06-30 13F CME GROUP Common Stock 12572Q105 35,623 -34,377 7,293 0.3150
2024-09-06 2022-03-31 13F/A-1 CME GROUP COM 12572Q105 70,000 35,876 105.13 16,650 113.57 69.4236
2022-05-12 2022-03-31 13F CME GROUP Common Stock 12572Q105 42,538 8,414 10,117 0.4355
2022-02-10 2021-12-31 13F CME Group Common Stock 12572Q105 34,124 1,359 4.15 7,796 23.04 0.4894
2021-11-12 2021-09-30 13F CME GROUP Common Stock 12572Q105 32,765 -2,730 -7.69 6,336 -16.07 0.4578
2021-08-13 2021-06-30 13F CME GROUP Common Stock 12572Q105 35,495 1,298 3.80 7,549 8.09 0.7293
2021-05-17 2021-03-31 13F CME GROUP Common Stock 12572Q105 34,197 1,386 4.22 6,984 16.93 0.6523
2021-02-12 2020-12-31 13F CME GROUP Common Stock 12572Q105 32,811 -355 -1.07 5,973 7.64 1.0162
2020-11-13 2020-09-30 13F CME GROUP Common Stock 12572Q105 33,166 33,166 5,549 1.1145
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.